Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Fludarabine

A purine analogue synthesised in 1968 by John Montgomery and Kathleen Hewson at the Southern Research Institute, approved in the United States in 1991 for chronic lymphocytic leukaemia. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.

Did you know?It is a fluorinated relative of the antiviral vidarabine: the fluorine atom makes it relatively resistant to adenosine deaminase, the enzyme that inactivates many adenosine analogues.

FludarabineGo to the active ingredient →
FludarabineActive ingredientFludarabineCat. No. P-F071-001CAS 21679-14-1

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.